Development and validation of a competitive risk model in patients with rectal cancer: based on SEER database
- PMID: 37735712
- PMCID: PMC10515244
- DOI: 10.1186/s40001-023-01357-3
Development and validation of a competitive risk model in patients with rectal cancer: based on SEER database
Abstract
Background: Rectal cancer is one of the most common malignancies. To predict the specific mortality risk of rectal cancer patients, we constructed a predictive nomogram based on a competing risk model.
Methods: The information on rectal cancer patients was extracted from the SEER database. Traditional survival analysis and specific death analysis were performed separately on the data.
Results: The present study included 23,680 patients, with 16,580 in the training set and 7100 in the validation set. The specific mortality rate calculated by the competing risk model was lower than that of the traditional survival analysis. Age, Marriage, Race, Sex, ICD-O-3Hist/Behav, Grade, AJCC stage, T stage, N stage, Surgery, Examined LN, RX SUMM-SURG OTH, Chemotherapy, CEA, Deposits, Regional nodes positive, Brain, Bone, Liver, Lung, Tumor size, and Malignant were independent influencing factors of specific death. The overall C statistic of the model in the training set was 0.821 (Se = 0.001), and the areas under the ROC curve for cancer-specific survival (CSS) at 1, 3, and 5 years were 0.842, 0.830, and 0.812, respectively. The overall C statistic of the model in the validation set was 0.829 (Se = 0.002), and the areas under the ROC curve for CSS at 1, 3, and 5 years were 0.851, 0.836, and 0.813, respectively.
Conclusions: The predictive nomogram based on a competing risk model for time-specific mortality in patients with rectal cancer has very desirable accuracy. Thus, the application of the predictive nomogram in clinical practice can help physicians make clinical decisions and follow-up strategies.
Keywords: Competitive risk model; Rectal cancer; SEER database; Validation.
© 2023. BioMed Central Ltd., part of Springer Nature.
Conflict of interest statement
The authors declare that they have no conflicts of interest to report regarding the present study.
Figures
Similar articles
-
The nomograms for predicting overall and cancer-specific survival in elderly patients with early-stage lung cancer: A population-based study using SEER database.Front Public Health. 2022 Sep 8;10:946299. doi: 10.3389/fpubh.2022.946299. eCollection 2022. Front Public Health. 2022. PMID: 36159305 Free PMC article. Clinical Trial.
-
A Web-Based Prediction Model for Cancer-Specific Survival of Elderly Patients With Hypopharyngeal Squamous Cell Carcinomas: A Population-Based Study.Front Public Health. 2022 Jan 13;9:815631. doi: 10.3389/fpubh.2021.815631. eCollection 2021. Front Public Health. 2022. PMID: 35096758 Free PMC article. Clinical Trial.
-
A nomogram to predict the prognosis of patients with unresected rectal adenocarcinoma undergoing chemoradiotherapy: a population-based study.J Cancer. 2021 Jun 11;12(16):4745-4761. doi: 10.7150/jca.61642. eCollection 2021. J Cancer. 2021. PMID: 34234846 Free PMC article.
-
A nomogram for predicting cause-specific mortality among patients with cecal carcinoma: a study based on SEER database.BMC Gastroenterol. 2023 May 23;23(1):177. doi: 10.1186/s12876-023-02802-7. BMC Gastroenterol. 2023. PMID: 37221487 Free PMC article.
-
Analysis of prognostic factors of metastatic endometrial cancer based on surveillance, epidemiology, and end results database.Front Surg. 2023 Jan 6;9:1001791. doi: 10.3389/fsurg.2022.1001791. eCollection 2022. Front Surg. 2023. PMID: 36684133 Free PMC article. Review.
References
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources